Skip to main content

Illumina Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

51
Companies
$925.9M
Total invested
$26.5M
Avg. check
24
Industries
Biotechnology 23Health Care 12Medical 9Life Science 8Genetics 5Biopharma 4+18 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 51
Human Longevity
August 2024

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

Biotechnology · San Diego$39.8M Series B
NuCicer
July 2025

NuCicer offers high-protein chickpea ingredients with added value in the agri-food system.

Agriculture · Davis$11.5M Series A
SyntaxBio
June 2026

Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.

Biotechnology · Chicago$14.4M Series A
Infinity Bio
June 2025

Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.

Biometrics · Baltimore$8.0M Series A
Arima Genomics
June 2025

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

Biotechnology · San Diego$22.0M Series C
SonoThera
June 2026

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

Biopharma · South San Francisco$125.0M Series B
Tagomics
June 2025

Tagomics transforms disease diagnosis through comprehensive multiomic profiling.

Biotechnology · Cambridge$1.2M Grant
Pluton Biosciences
May 2023

Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.

AgTech · Saint Louis$16.5M Series A
Kallyope
May 2023

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Biotechnology · New York$8.2M Grant
Biosynch.ai
April 2025

Pioneering the future of medicine through artificial intelligence and computational biology.

San Diego$4.2M Seed
Lightcast Discovery
April 2026

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.

Biotechnology · Cambridge$27.0M Venture - Series Unknown
Fluent BioSciences
March 2024

Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.

Biotechnology · WatertownGrant
SQZ Biotech
March 2022

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Biotechnology · Watertown$2.0M Grant
Twist Bioscience
February 2022

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

B2B · San Francisco$250.0M Post-IPO Equity
Walking Fish Therapeutics
February 2022

Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.

Biotechnology · San Francisco$23.0M Series A
Pattern Bioscience
August 2025

Pattern Bioscience is a biotech diagnostics company that helps to combat the problem of antibiotic resistance.

Biotechnology · Austin$44.2M Venture - Series Unknown
Integrated Biosciences
October 2024

Integrated Biosciences develops next-generation therapeutics.

Biopharma · Redwood City$17.2M Seed
Stilla Technologies
February 2024

Stilla Technologies is a Paris-based european biotechnology company.

Biotechnology · Villejuif$26.5M Series C
Broken String Biosciences
September 2023

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

Biotechnology · Cambridge$15.0M Series A
LetsGetChecked
January 2025

LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.

Biotechnology · Atlanta$165.0M Series F
Protillion Biosciences
December 2022

Protillion Biosciences specializes in the design and development of protein-based drugs.

Biopharma · Burlingame$18.0M Series A
Hepta Bio
November 2025

Hepta Bio detect, monitor, and direct the most effective liver treatment.

Biotechnology · San Francisco$6.7M Seed
Sherlock Biosciences
November 2022

Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.

Biotechnology · CambridgeGrant
Precede Biosciences
January 2026

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

Biopharma · Boston$63.5M Series B

Where Illumina Ventures invests

Biotechnology23
Health Care12
Medical9
Life Science8
Genetics5
Biopharma4

About Illumina Ventures's portfolio

How many companies has Illumina Ventures invested in?

Illumina Ventures has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Illumina Ventures invest in?

Illumina Ventures's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Genetics. The firm invests across 24 different industry categories.

What is Illumina Ventures's largest investment?

Among tracked funding rounds, Twist Bioscience received $250.0M in a Post-IPO Equity round. Illumina Ventures's total known invested capital is $925.9M.

What is the average investment size for Illumina Ventures?

Illumina Ventures's average investment size is $26.5M across its portfolio of 51 companies.

What are Illumina Ventures's most recent investments?

Recent Illumina Ventures portfolio additions include Human Longevity, NuCicer, SyntaxBio, Infinity Bio, Arima Genomics. These companies were founded in 2020 or later.

Reach the founders behind these 51 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →